Dante P I Capaldi1, Khadija Sheikh1, Fumin Guo2, Sarah Svenningsen1, Roya Etemad-Rezai3, Harvey O Coxson4, Jonathon A Leipsic4, David G McCormack5, Grace Parraga6. 1. Imaging Research Laboratories, Robarts Research Institute, 1151 Richmond Street North, London, Ontario, Canada N6A 5B7; Department of Medical Biophysics, The University of Western Ontario, London, Ontario, Canada. 2. Imaging Research Laboratories, Robarts Research Institute, 1151 Richmond Street North, London, Ontario, Canada N6A 5B7; Graduate Program in Biomedical Engineering, The University of Western Ontario, London, Ontario, Canada. 3. Department of Medical Imaging, The University of Western Ontario, London, Ontario, Canada. 4. James Hogg Research Centre, University of British Columbia, Vancouver, British Columbia, Canada. 5. Division of Respirology, Department of Medicine, The University of Western Ontario, London, Ontario, Canada. 6. Imaging Research Laboratories, Robarts Research Institute, 1151 Richmond Street North, London, Ontario, Canada N6A 5B7; Department of Medical Biophysics, The University of Western Ontario, London, Ontario, Canada; Graduate Program in Biomedical Engineering, The University of Western Ontario, London, Ontario, Canada; Department of Medical Imaging, The University of Western Ontario, London, Ontario, Canada. Electronic address: gparraga@robarts.ca.
Abstract
RATIONALE AND OBJECTIVES: In this proof-of-concept demonstration, we aimed to quantitatively and qualitatively compare pulmonary ventilation abnormalities derived from Fourier decomposition of free-breathing (1)H magnetic resonance imaging (FDMRI) to hyperpolarized (3)He MRI in subjects with chronic obstructive pulmonary disease (COPD) and bronchiectasis. MATERIALS AND METHODS: All subjects provided written informed consent to a protocol approved by a local research ethics board and Health, Canada, and they underwent MRI, computed tomography (CT), spirometry, and plethysmography during a single 2-hour visit. Semiautomated segmentation was used to generate ventilation defect measurements derived from FDMRI and (3)He MRI, and these were compared using analysis of variance and Pearson correlations. RESULTS: Twenty-six subjects were evaluated including 12 COPD subjects (67 ± 9 years) and 14 bronchiectasis subjects (70 ± 11 years). For COPD subjects, FDMRI and (3)He MRI ventilation defect percent (VDP) was 7 ± 6% and 24 ± 14%, respectively (P < .001; bias = -16 ± 9%). In COPD subjects, FDMRI was significantly correlated with (3)He MRI VDP (r = .88; P = .0001), (3)He MRI apparent diffusion coefficient (r = .71; P < .05), airways resistance (r = .60; P < .05), and RA950 (r = .80; P < .01). In subjects with bronchiectasis, FDMRI VDP (5 ± 3%) and (3)He MRI VDP (18 ± 9%) were significantly different (P < .001) and not correlated (P > .05). The Dice similarity coefficient (DSC) for FDMRI and (3)He MRI ventilation was 86 ± 7% for COPD and 86 ± 4% for bronchiectasis subjects (P > .05); the DSC for FDMRI ventilation defects and CT RA950 was 19 ± 20% in COPD and 2 ± 3% in bronchiectasis subjects (P < .01). CONCLUSIONS: FDMRI and (3)He MRI VDP were strongly related in COPD but not in bronchiectasis subjects. In COPD only, FDMRI ventilation defects were spatially related with (3)He ventilation defects and emphysema.
RATIONALE AND OBJECTIVES: In this proof-of-concept demonstration, we aimed to quantitatively and qualitatively compare pulmonary ventilation abnormalities derived from Fourier decomposition of free-breathing (1)H magnetic resonance imaging (FDMRI) to hyperpolarized (3)He MRI in subjects with chronic obstructive pulmonary disease (COPD) and bronchiectasis. MATERIALS AND METHODS: All subjects provided written informed consent to a protocol approved by a local research ethics board and Health, Canada, and they underwent MRI, computed tomography (CT), spirometry, and plethysmography during a single 2-hour visit. Semiautomated segmentation was used to generate ventilation defect measurements derived from FDMRI and (3)He MRI, and these were compared using analysis of variance and Pearson correlations. RESULTS: Twenty-six subjects were evaluated including 12 COPD subjects (67 ± 9 years) and 14 bronchiectasis subjects (70 ± 11 years). For COPD subjects, FDMRI and (3)He MRI ventilation defect percent (VDP) was 7 ± 6% and 24 ± 14%, respectively (P < .001; bias = -16 ± 9%). In COPD subjects, FDMRI was significantly correlated with (3)He MRI VDP (r = .88; P = .0001), (3)He MRI apparent diffusion coefficient (r = .71; P < .05), airways resistance (r = .60; P < .05), and RA950 (r = .80; P < .01). In subjects with bronchiectasis, FDMRI VDP (5 ± 3%) and (3)He MRI VDP (18 ± 9%) were significantly different (P < .001) and not correlated (P > .05). The Dice similarity coefficient (DSC) for FDMRI and (3)He MRI ventilation was 86 ± 7% for COPD and 86 ± 4% for bronchiectasis subjects (P > .05); the DSC for FDMRI ventilation defects and CT RA950 was 19 ± 20% in COPD and 2 ± 3% in bronchiectasis subjects (P < .01). CONCLUSIONS: FDMRI and (3)He MRI VDP were strongly related in COPD but not in bronchiectasis subjects. In COPD only, FDMRI ventilation defects were spatially related with (3)He ventilation defects and emphysema.
Authors: Fumin Guo; Dante Capaldi; Miranda Kirby; Khadija Sheikh; Sarah Svenningsen; David G McCormack; Aaron Fenster; Grace Parraga Journal: J Med Imaging (Bellingham) Date: 2018-06-28
Authors: Eric A Hoffman; David A Lynch; R Graham Barr; Edwin J R van Beek; Grace Parraga Journal: J Magn Reson Imaging Date: 2015-07-22 Impact factor: 4.813
Authors: Andreas Voskrebenzev; Till F Kaireit; Filip Klimeš; Gesa H Pöhler; Lea Behrendt; Heike Biller; Korbinian Berschneider; Frank Wacker; Tobias Welte; Jens M Hohlfeld; Jens Vogel-Claussen Journal: Radiol Cardiothorac Imaging Date: 2022-04-21